Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the...
United States Jim Martinez Anja Krammer Kevinj Curran Memorial Sloan Kettering Cancer Center American Society Of Pediatric Hematology Oncology
Source: prnewswire.com